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Chapter 2
How to Identify Exposed Women Who Are Infected
with Neisseria gonorrhoeae
Stephanie E. McLaughlin and J. McLeod Griffiss
Abstract
Treatment trials of antibiotics for Neisseria gonorrhoeae infections frequently enroll primarily men with
urethritis, as the diagnosis of acute gonococcal infection in men with urethritis is easily made by Gram stain
of the urethral exudate, followed by confirmatory culture or nucleic acid amplification tests (NAATs).
Enrolling women in treatment trials is of great importance, but N. gonorrhoeae cervical infections cause
nonspecific symptoms. This makes it difficult to conduct interventional trials, as large numbers of women
with nonspecific symptoms need to be screened for infection. Gram stain of cervical secretions has a
strikingly low sensitivity, and culture and/or NAAT results are not available at the time of screening. This
necessitates recall and delayed treatment of infected women who may not return and who may spread the
infection during the interval. In this chapter we present an algorithm, derived from a comparison of women
who did, or did not, become infected during exposure, which identifies those women who are highly likely
to be infected before culture and/or NAAT results are available. The algorithm provides an efficient way to
conduct interventional trials in women without the problem of recall and delayed treatment.
Key words Neisseria gonorrhoeae, Cervical infections, Cervical discharge, Vaginal pH, Cervical
inflammation
1 Introduction
Treatment trials of antibiotics for Neisseria gonorrhoeae infections
usually enroll primarily men with urethritis, as the diagnosis of
acute gonococcal infection in men with urethritis is easily made
by Gram stain of the urethral exudate, followed by confirmatory
culture or nucleic acid amplification tests (NAATs) [1]. This allows
enrollment during the initial clinic visit with subsequent censoring
of the very few subjects whose infections will not be confirmed.
As N. gonorrhoeae acquires resistance to the currently recom-
mended antimicrobials, enrolling women in treatment trials of
newer agents is of great importance. However, N. gonorrhoeae
cervical infections are asymptomatic in many women, cause non-
specific symptoms in others, and cannot be presumptively
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diagnosed with Gram stain of cervical secretions, as these have a
strikingly low sensitivity (<0.1) [2]. This makes it difficult to
conduct intervention trials. Asymptomatic women are unlikely to
be screened, and large numbers of women with nonspecific symp-
toms will need to be screened for infection, but not enrolled until
culture and/or NAAT results are available. This necessitates recall
and delayed treatment of infected women who may not return to
clinic and who may spread the infection during the interval.
One way to improve the efficiency of enrollment of infected
women would be to recruit women who present to clinic reporting
gonococcal exposure [1], but only 60–65% of women are infected
with N. gonorrhoeae during a single exposure [3–5]. An algorithm
that identifies women who are highly likely to have been infected
during exposure, before culture and/or NAAT results are available,
would allow for more efficient enrolment of women in interven-
tional trials without the problem of recall and delayed treatment.
We developed such an algorithm by comparing the medical and
sexual histories, symptoms and physical findings of women who
resisted infection during exposure with the same information from
women who were infected during exposure.
1.1 Predictors
of Cervical Infection
During Exposure:
Comparing Women
Who Resisted Infection
with Those Who
Did Not
Here we present the development of the algorithm and how to use
it to efficiently recruit women into treatment trials. The algorithm
was developed by enrolling women who presented to one of the
Baltimore City Health Department Sexually Transmitted Infection
(STI) clinics with a “partner notification card” indicating sexual
contact with a man who had been diagnosed with gonorrhea. We
then compared sexual histories, symptoms and physical findings
between those who were infected and those who resisted infection.
2 Materials
1. Subjects: women who have had sexual contact with an
infected man.
2. A detailed history: a questionnaire that records sexual history—
past prior STIs (including prior gonococcal infections), type of
sexual contact involved (oral or anal sex in addition to vaginal
intercourse), and the time between exposure and reporting to
the clinic.
3. A cervicovaginal physical examination by a clinician experi-
enced in the diagnosis of STIs.
4. Amsel criteria for bacterial vaginosis (BV) [6]: (a) A thin (i.e.,
of low viscosity) and homogeneous-appearing vaginal dis-
charge. (b) Vaginal pH >4.5. (c) The release of a fishy amine
odor on addition of 10% (v/v) potassium hydroxide (KOH) to
a drop of vaginal discharge (whiff test). (d) Clue cells on saline
wet mount of vaginal discharge.
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3 Methods
1. Recruit and enroll women who present to clinic having been
identified as a partner of a man with acute gonococcal
infection.
2. Record the presence of vaginal discharge on pelvic exam and
whether it meets the Amsel criteria (see Note 1).
3. Measure vaginal pH by indicator strip (range: 4.0–7.0) (see
Note 2).
4. Record the presence of cervical discharge on examination, and
the presence of white blood cells (WBC) in cervical secretions
(Table 1) (see Note 3).
5. Grade the degree of inflammation, as judged by the presence
and number of leukocytes seen by the clinician on wet mount
of the cervix (see Note 4).
6. Collect cervical swabs for gram stain (see Note 5), culture and
NAATs (see Note 6), and wet mounts for KOH whiff test (see
Note 7).
7. Scrutinize the sexual histories and symptoms recorded on the
questionnaire (Table 2) (see Note 8) with particular attention
to a history of oral sex and anal sex practices (see Note 9).
8. Calculate the interval between exposure and reporting to clinic
(see Note 10).
9. Select female sexual contacts of men diagnosed with gonorrhea
thatpresentedwithin30daysof sexual exposure andhave a vaginal
pH5.0 but6.5 for enrolment (seeNote 11) and follow one of
the two models in the algorithm (Fig. 1). The algorithm was
constructed using the method detailed inNote 12.
10. Algorithm Model 1, which relies only on vaginal pH (Fig. 1—
Model 1, Tables 3 and 4), enables enrolment of a larger num-
ber of infected women, but results in a lower percentage of
Table 1
Cervicovaginal findings and risk of gonococcal infection during exposure
Infected Uninfected
paN % of all infected N % of all uninfected
Vaginal discharge observed by clinician 15 39.5 10 43.5 0.79
Cervical discharge observed by clinician 16 42.1 4 17.4 0.05
Inflammation (>5 WBC/hpf) 24 80 15 78.9 0.11
Positive “whiff” test 14 36.8 6 26.1 0.42
aFisher’s exact test
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gonococcal-positive women enrolled. For example, if a study
needs to enroll ~80 N. gonorrhoeae infected women, Model 1
could be used: 226 women who present reporting exposure to
Table 2
Sexual history and symptoms and risk of gonococcal infection during exposure
N Infected Uninfected
All subjects 61 38 62.30% 23 37.70%
History and symptoms N % of infected N % of uninfected pa
Past gonococcal infection 25 15 39.5 10 42.5 0.79
Oral sexb 28 15 40.5 13 56.5 0.29
Mean days between contact and exam 61 24.3 25.76
Median days between contact and exam 11 (0–120 8 (0–107)
Any symptom 34 21 55.3 13 56.5 0.07
Vaginal discharge reported by subject 27 14 36.8 13 56.5 0.11
Abdominal pain 18 12 31.6 6 26.1 0.78
Regular douching 20 12 31.6 8 34.8 0.78
Hormonal contraception 15 8 21.1 7 30.4 0.54
aFisher’s exact test
bAll reported vaginal intercourse, as well
Fig. 1 Algorithm Models 1 and 2 begin selection by assessing vaginal pH of women exposed within 30 days of
presentation to clinic. Model 2 continues by selecting women with a high likelihood of being infected by
Neisseria gonorrhoeae during exposure based on vaginal pH and the presence or absence of cervical
discharge
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a man with gonorrhea could be screened for vaginal pH, and
the 100 women with a vaginal pH of 5.0–6.5 could be
enrolled. This would result in around 84 positive women
enrolled (16% uninfected women and 84% of infected women
enrolled).
11. Alternately, if a study needs to enroll a small number of women,
Model 2 could be used; Model 2 adds cervical discharge to
vaginal pH (Fig. 1—Model 2). Fewer women will be enrolled,
but virtually all of them will be infected. For example, if a study
needs to enroll only ~16 infected women, Model 2 could be
used: 86 women who presented reporting exposure to an
infected man could be screened for both vaginal pH and cervi-
cal discharge sequentially; the 16 women with vaginal pH of
5.0–6.5 and cervical discharge would be enrolled, and this
would result in 16 (100%) gonococcus-infected women being
enrolled.
4 Notes
1. The BV discharge has a milk-like consistency and is distinctly
not floccular, granular, curd-like, stringy, or clumped. Vaginal
discharge of any sort was reported more frequently by unin-
fected women but was not always consistent with BV [7–9].
2. A vaginal pH>4.5 is one of the four Amsel criteria for bacterial
vaginosis [6].
3. Only cervical discharge, but not vaginal discharge, was signifi-
cantly more common among infected women than those who
were uninfected ( p ¼ 0.04, Fisher’s exact test).
4. Grade 4 inflammation was seen only in infected women
(N ¼ 10). Scale: 1 ¼ 0–5 neutrophils/high-powered field
(hpf; 100 magnification), 2 ¼ 6–30 neutrophils/hpf,
3 ¼ 31–100 neutrophils/hpf, and 4 ¼ >100 neutrophils/hpf.
5. Gram-negative diplococci were found in cervical secretions of
only four women, including one uninfected woman. Sensitivity
of gram stain in this study was only 0.079, but specificity was
high (0.957).
6. Negative cultures will need to be confirmed by NAAT [1]. In
our study, 38 of the 61 enrolled women were infected (62%), as
determined by a positive culture (35) or a subsequent positive
NAAT (3) after a negative culture.
7. A positive “whiff” test—the release of a fishy amine odor on
addition of 10 % (v/v) KOH to a drop of fluid on a slide—is
one of the four Amsel criteria for BV. Infected women were
more likely to have a positive whiff test (37%) than uninfected
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women (26%), but the difference was not significant (Table 1).
Women who have BV by Amsel criteria should be treated.
8. Neither sexual practices nor a history of prior gonococcal infec-
tions nor any symptoms, including vaginal discharge and
abdominal pain, differed between infected and uninfected
exposed women (Table 2). It is unlikely that enrolling more
women would reveal any significant differences. Note, in par-
ticular, that there was no difference in symptoms between
infected and uninfected exposed women, so symptoms cannot
be used to identify infected women. Platt et al. reported that
infected women were more likely to have abnormal adnexal
findings on exam [4], but abdominal pain was infrequently
experienced by women in our study and did not discriminate
between infected and uninfected women.
9. Oral sex is commonly acknowledged by exposed women
(Table 2) and likely is more common than is acknowledged,
as it may be considered part of normal foreplay. Questions of
sexual practices need to be asked in the street vernacular. All
women who acknowledge performing fellatio should provide
pharyngeal cultures, as they may have pharyngeal, but not
cervical infections. These same considerations apply to anal
sex, asked in the street vernacular, and to anal cultures.
10. Because vaginal pH varies over time, the longer the interval,
the less reliable is the pH as a marker of risk (Table 3).
11. Eighty-four percent of women who have a pH 5 and 6.5,
measured within 30 days (~1 menstrual cycle) of exposure will
be infected. Those who have a pH 5 and 6.5, measured
within 5 days, will certainly be infected (Table 4).
12. Building the algorithm (generating a “predictive factors
model”): STATA 14 statistical software used for logistical
regression. Logistical regression was used to investigate the
relationship between possible predictive factors (e.g., pH)
and gonococcal infection and any relationship between a diag-
nosis of gonococcal infection and associated symptoms (e.g.,
cervical discharge) while accounting for possible confounders
Table 3
Risk as a function of vaginal pH range
pH range N Culture positive Percent
4.0–4.9 23 11 47.8
5.0–5.7 13 11 84.6
5.8–6.5 16 11 68.8
>6.5 4 2 50
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(e.g., age). The “predictive factor model” was built using
backward variable selection with variable inflation factor (vif)
analysis to exclude possible collinear variables. Covariates
included were taken from a detailed history of women present-
ing to clinic as gonococcal contacts with partner notification
cards. This included age at sexual debut, the number of lifetime
sexual partners, prior STIs, including gonococcal infections,
the number of gonococcal infections, gonococcal infections in
the past 6 months, whether the subject contact involved oral or
anal sex in addition to vaginal intercourse, the time between
exposure and reporting to the clinic, the date of last menstrual
period (LMP) and the use, and type, of hormonal contracep-
tion if any. A history of regular douching was recorded, along
with a history of vaginal discharge and its duration, and a
history of abdominal pain. There was no difference in symp-
toms between infected and uninfected exposed women, so
symptoms cannot be used to identify infected women
(Table 2). Menstrual cycle phase, and bacterial vaginosis by
Amsel Criteria [6] were excluded from the “predictive factors
model” due to colinearity with pH.
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